Pop-Up Thingie
Sidebar
>>> Magnum BBS <<<
Home
Forum
Files
Dark
Log in
Username
Password
Sidebar
Forum
Usenet
TALK.POLITICS.CHINA
=?utf-8?Q?[WSJ]=20=E6=AC=A7=E7=9B=9F=E8=B0=83=E6=9F=A5=E5=87=8F=E8=82=A
From
Mobot
@21:1/5 to
All
on Tue Jul 11 15:28:42 2023
XPost: alt.chinese.text
一支总部位于丹麦的诺和诺德生产的诺和泰。
_图片来源:F. Martin Ramin/The Wall Street Journal_
Melanie Evans
2023年7月11日08:30 CST 更新
欧洲药品安全监管部门正在对诺和泰(Ozempic)进行审查,此前收到了与这种流行的减肥药和另一种同类药物有关的自杀念头的报告。
欧洲药品管理局(EMA)周一表示,在得知三名服药者报告有自残或自杀念头后,该局正在评估患者服用诺和诺德(Novo Nordisk, NVO)生产的这类药物的安全风险。
EMA称,在欧盟,自杀行为未被列为诺和泰和一种名为Saxenda的相关药物的副作用。
诺和诺德称,该公司对诺和泰和Saxenda的研究以及对其使用的持续监测未显示出该药与自杀想法或自残念头有关。
总部位于丹麦的诺和诺德在纽约证券交易所挂牌的美国存托股票周一午盘持平。
相关阅读:
“金刚级”减肥药将至
https://cn.wsj.com/amp/articles/%E6%AC%A7%E7%9B%9F%E8%B0%83%E6%9F%A5%E5%87%8F%E8%82%A5%E8%8D%AF%E8%AF%BA%E5%92%8C%E6%B3%B0%E6%98%AF%E5%90%A6%E4%BC%9A%E5%A2%9E%E5%8A%A0%E8%87%AA%E6%9D%80%E5%80%BE%E5%90%91-1f73303b
Tue, 11 Jul 2023 09:33:05 +0800
--
Mobot
If you have any comments about this article, you can simply leave them by replying to this post. However, if you have any comments about this bot, please leave your message in the cn.fan group.
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)
Who's Online
System Info
Sysop:
Keyop
Location:
Huddersfield, West Yorkshire, UK
Users:
300
Nodes:
16 (
2
/
14
)
Uptime:
71:18:38
Calls:
6,712
Files:
12,244
Messages:
5,356,970